| 1 |
Ipsen DH, Tveden-Nyborg P. Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact. Biomedicines 2021;9:93. [PMID: 33477873 DOI: 10.3390/biomedicines9010093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Salas A, Vázquez P, Bello AR, Báez D, Almeida TA. Dual agonist-antagonist effect of ulipristal acetate in human endometrium and myometrium. Expert Rev Mol Diagn 2021;21:851-7. [PMID: 34110938 DOI: 10.1080/14737159.2021.1941878] [Reference Citation Analysis]
|
| 3 |
Brigstock DR. Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics. Cells 2021;10:1596. [PMID: 34202136 DOI: 10.3390/cells10071596] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 4 |
Weiskirchen R. Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis". Cells 2020;9:E1105. [PMID: 32365575 DOI: 10.3390/cells9051105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Fang PP, Pan CW, Lin W, Li J, Huang SS, Zhou GY, Du WJ, Li Q. ASK1 Enhances Angiotensin II-Induced Liver Fibrosis In Vitro by Mediating Endoplasmic Reticulum Stress-Dependent Exosomes. Mediators Inflamm 2020;2020:8183713. [PMID: 33223956 DOI: 10.1155/2020/8183713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Garbuzenko DV. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis . World J Clin Cases 2022; 10(12): 3662-3676 [DOI: 10.12998/wjcc.v10.i12.3662] [Reference Citation Analysis]
|
| 7 |
Azparren-Angulo M, Royo F, Gonzalez E, Liebana M, Brotons B, Berganza J, Goñi-de-Cerio F, Manicardi N, Abad-Jordà L, Gracia-Sancho J, Falcon-Perez JM. Extracellular vesicles in hepatology: Physiological role, involvement in pathogenesis, and therapeutic opportunities. Pharmacol Ther 2021;218:107683. [PMID: 32961265 DOI: 10.1016/j.pharmthera.2020.107683] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Newman LA, Muller K, Rowland A. Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04256-8] [Reference Citation Analysis]
|
| 9 |
Li X, Chen R, Kemper S, Brigstock DR. Structural and Functional Characterization of Fibronectin in Extracellular Vesicles From Hepatocytes. Front Cell Dev Biol 2021;9:640667. [PMID: 33816490 DOI: 10.3389/fcell.2021.640667] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 10 |
Mastoridou EM, Goussia AC, Glantzounis GK, Kanavaros P, Charchanti AV. Autophagy and Exosomes: Cross-Regulated Pathways Playing Major Roles in Hepatic Stellate Cells Activation and Liver Fibrosis. Front Physiol 2022;12:801340. [DOI: 10.3389/fphys.2021.801340] [Reference Citation Analysis]
|
